CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial ...Middle East

PR Newswire - News
MELBOURNE, Australia, Dec. 4, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, has successfully completed its Phase 1 clinical trial of CYP-006TK in diabetic foot ulcers...

Read More Details
Finally We wish PressBee provided you with enough information of ( CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial )

Apple Storegoogle play

Also on site :